LGI1 and encephalitis: In a retrospective study in the UK (29), 77% (20/26) of anti-LGI1 encephalitis patients experienced FBDS prior to the development of limbic encephalitis and found that early immunotherapy for FBDS might prevent progression to cognitive impairment.